The Positive Feedback Mochi Health has built a genuine following, particularly among younger patients who discovered the platform through social media
The combination of GIP and glucagon receptor activation appears to produce additive benefits for liver fat reduction and metabolic health that neither receptor achieves alone
For patients requiring surgical procedures, recent 2024 multi-society guidance (including the American Society of Anesthesiologists) indicates that most patients can continue GLP-1 receptor agonists perioperatively
The Scripps LOCIT Trial The Scripps fully remote Long COVID Treatment or LoCITT (Lock-it) trial has a lot going for it
Despite this, people with type 2 diabetes tend to lose less weight on a GLP-1 than people who don't have the condition, and for reasons that aren't quite clear, says Silvana Obici, MD, chief of the division of endocrinology at Stony Brook Medicine and medical director of the Stony Brook University Hospital Diabetes Center in New York
The sticker price for Ozempic, Wegovy, Mounjaro and Zepbound in the U.S